EDTA (Ethylene diamine tetra acetic acid)
All rights reserved.
Discuss with your doctor before taking any alternative medicine. This article is for
reference only, it is not a medical advice. All rights reserved. Do not copy this article to
other website or blog.
PROPERTIES
Sodium or calcium EDTAs are chelators (sequestering agents; or chelating
agents) they bind to metals, such as nickel, copper, and iron, making them
unavailable to react with other ingredients in a product, or with compounds in
our body.
USES
EDTA is used to treat lead and mercury poisoning, and hard water. It prevents
calcium and magnesium to form insoluble soap films with soaps and detergents.
EDTA chelation therapy
The recently discovered increased risk of blood clots, leading to myocardial
infarction and sudden death beginning six months after medicated stents are
implanted in patients following percutaneous transluminal coronary angioplasty
(PTCA), has left cardiologists pondering what course of action to take. The
purpose of adding implanted medication to a stent is to prevent thrombin
accumulation and restenosis. However, these stents may increase, rather than
decrease, the risk.
Chappell LT. served as the primary investigator for a study that showed
cardiovascular patients treated with EDTA chelation therapy had a lower rate of
subsequent cardiac events, including myocardial infarction and death, than
those treated with cardiac medications, PTCA, or coronary artery bypass graft
(CABG). The data also indicated chelation therapy might be effective in
preventing thrombosis and cardiac events from stent implantation. There is
evidence EDTA chelation therapy might prevent hypercoagulability resulting
from the placement of stents, although not specifically medicated stents. Based
on the limited data currently available, intravenous EDTA may be safe and
effective for treating patients who have implanted medicated stents.
Prospective clinical trials are needed, and EDTA should be included in those
trials.
SOURCE
Should EDTA chelation therapy be used instead of long-term clopidogrel plus
aspirin to treat patients at risk from drug-eluting stents? Altern Med Rev. 2007
Jun;12(2):152-8.Click here to read